English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Transcranial direct current stimulation (tDCS) has attracted significant attention from patients and clinicians for its potential to elicit therapeutic benefit in a number of neurological and psychiatric conditions, and to facilitate rehabilitation after neurological injury.1 Tested indications include recovery of speech andmotor loss following stroke,2 mitigation of various forms of chronic pain,3 and reduction in signs and symptoms of particular types of depressive and anxiety disorders4 (for overview, see Kuo et al., 20145). The mechanisms of transcranial electrical stimulation have been systematically characterized over decades, while themost rigorous clinical trials have considered

The off-label use, utility and potential value of tDCS in the clinical care of particular neuropsychiatric conditions